What patient and disease characteristics do you consider when choosing a systemic therapy for patients with metastatic SCC?
Featuring Laura Ferris, MD, PhD |
Professor and Director of Clinical Trials, Dermatology
University of Pittsburgh
Pittsburgh, PA